ELVIA ORTIZ: Open Payments
NPI 1831675743 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 30 payments from 8 companies in 2025. Trend: 2023 $126 · 2024 $562 · 2025 $797
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 6 | $269 |
| Novo Nordisk Inc | 10 | $179 |
| Lilly USA, LLC | 5 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $86 |
| Sequel Med Tech, LLC | 4 | $74 |
| Tandem Diabetes Care, Inc. | 2 | $48 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $27 |
| Abbott Laboratories | 1 | $16 |
Products named: OMNIPOD, Wegovy, JARDIANCE, Kerendia, TWIIST, t:slim X2 Insulin Pump with Control-IQ, Rybelsus, Ozempic.
Industry payments across IL — which companies pay providers there.
